[1] SAINT-MARCOUX F, MARQUET P, JACQZ-AIGRAIN E, et al. Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients[J]. Clin Pharmacokinet,2006,45(9):905-922. doi:  10.2165/00003088-200645090-00003
[2] 蔡治涛, 刘宏, 朱方强, 等. 静脉用环孢素在肾移植中的应用[C]//2012中国器官移植大会论文集. 厦门, 2012: 99.
[3] 胡永芳, 周宏灏. CYP3A4, CYP3A5和MDR1基因多态性对环孢素处置的影响[J]. 中国药理学通报, 2005, 21(3):257-261. doi:  10.3321/j.issn:1001-1978.2005.03.001
[4] 侯明明, 侯颖, 宋洪涛, 等. 肾移植患者CYP3A4基因多态性对他克莫司疗效和不良反应的影响[J]. 中国药房, 2010, 21(26):2427-2429.
[5] QIU X Y, JIAO Z, ZHANG M, et al. Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients[J]. Eur J Clin Pharmacol,2008,64(11):1069-1084. doi:  10.1007/s00228-008-0520-8
[6] LI D Y, TENG R C, ZHU H J, et al. CYP3A4/5 polymorphisms affect the blood level of cyclosporine and tacrolimus in Chinese renal transplant recipients[J]. Int J Clin Pharmacol Ther,2013,51(6):466-474. doi:  10.5414/CP201836
[7] 侯明明, 宋洪涛, 王庆华, 等. 肾移植患者CYP3A5*3基因多态性对他克莫司血药浓度/剂量比和疗效的影响[J]. 中国医院药学杂志, 2010, 30(4):313-316.
[8] 谢宇, 宋洪涛, 王庆华, 等. CYP3A5* 3和MDR1 G2677T/A基因多态性对肾移植患者环孢素A血药浓度及疗效的影响[J]. 中国药学杂志, 2011, 46(20):1591-1596.
[9] SUN B, GUO Y K, GAO J W, et al. Influence of CYP3A and ABCB1 polymorphisms on cyclosporine concentrations in renal transplant recipients[J]. Pharmacogenomics,2017,18(16):1503-1513. doi:  10.2217/pgs-2017-0127
[10] ZHANG Y, LI J L, FU Q, et al. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients[J]. Acta Pharmacol Sin,2013,34(4):555-560. doi:  10.1038/aps.2012.200
[11] GARCÍA M, MACÍAS R M, CUBERO J J, et al. ABCB1 polymorphisms are associated with cyclosporine-induced nephroto-xicity and gingival hyperplasia in renal transplant recipients[J]. Eur J Clin Pharmacol,2013,69(3):385-393. doi:  10.1007/s00228-012-1355-x
[12] DAI Y, IWANAGA K, LIN Y S, et al. In vitro metabolism of cyclosporine A by human kidney CYP3A5[J]. Biochem Pharmacol,2004,68(9):1889-1902. doi:  10.1016/j.bcp.2004.07.012
[13] LAMBA J, LAMBA V, STROM S, et al. Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression[J]. Drug Metab Dispos,2008,36(1):169-181. doi:  10.1124/dmd.107.016600
[14] WANG X D, DENG X Y, CHEN J, et al. Single nucleotide polymorphisms of the pregnane x receptor gene in Han Chinese and a comparison with other ethnic populations[J]. Pharmacology,2008,81(4):350-354. doi:  10.1159/000123687
[15] 陈启晨, 胡正威, 王威, 等. 孕烷X受体基因多态性与中国肾移植受者他克莫司浓度/剂量比值的相关性[J]. 中国临床药理学杂志, 2016, 32(17):1557-1560.
[16] HUANG N W, PANDEY A V, AGRAWAL V, et al. Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler syndrome and disordered steroidoge-nesis[J]. Am J Hum Genet,2005,76(5):729-749. doi:  10.1086/429417
[17] ELENS L, HESSELINK D A, BOUAMAR R, et al. Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclospo-rine A in renal transplant patients[J]. Ther Drug Monit,2014,36(1):71-79.